Long-term follow-up of pediatric transplant recipients: Mycophenolic acid trough levels are not a good indicator for long-term graft function

Clinical Transplantation

Volumn 18, Issue 5, 2004, Pages 576-579

  Pape, Lars ^a   Ehrich, J H H ^a   Offner, G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Children; Drug monitoring; Kidney transplantation; Mycophenolic acid

Indexed keywords

CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CHILD; CLINICAL ARTICLE; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; LONG TERM CARE; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADOLESCENT; AREA UNDER CURVE; BIOPSY; CHILD; CHILD, PRESCHOOL; CREATININE; CYCLOSPORINE; DRUG MONITORING; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; INFANT; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MYCOPHENOLIC ACID; PREDNISOLONE; PRODRUGS; TREATMENT OUTCOME;

EID: 4644344146     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00229.x     Document Type: Article

References (15)

1. Staskewitz A, Kirste G, Toenshoff B et al. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study group. Transplantation 2001: 71: 638.
2. David-Neto E, Araujo LM, Lemos FC et al. Introduction of mycophenolate mofetil and cyclosporine reduction in children with chronic transplant nephropathy. Pediatr Transplant 2001: 5: 302.
3. Henne T, Latta K, Strehlau J, Pape L, Ehrich JHH, Offner G. Mycophenolate mofetil induced reversal of glomerular filtration loss in children with chronic allograft nephropathy. Transplantation 2003: 76: 1326.
4. Weber LT, Hocker B, Mehls O, Toenshoff B. Mycophenolate mofetil in pediatric renal transplantation. Minerva Urol Nefrol 2003: 55: 91.
5. Bullingham RES, Nicholls A, Hale M. Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transplant Proc 1996: 28: 925.
6. Shaw LM, Korecka M, DeNorfrio D et al. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Clin Biochem 2001: 34: 17.
7. Weber LT, Shipkova M, Armstrong VW et al. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J Am Soc Nephrol 2002: 13: 759.
8. Cox VC, Ensom MHH. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring? Ther Drug Monit 2003: 25: 137.
9. Pape L, Henne T, Offner G et al. Computer-assisted-quantification of fibrosis in chronic allograft nephropathy by PicroSiriusRed-staining: A new tool for predicting long term graft function. Transplantation 2003: 76: 955.
10. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987: 34: 571.
11. Behrend M. Mycophenolate mofetil: suggested guidelines for use in kidney transplantation. BioDrugs 2001: 15: 37.
12. VanGelder T, Hilbrands LB, Vanrenterghem Y et al. A randomized double-blind multicenter plasma-concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1999: 68: 261.
13. Filler G, Mai I. Limited sampling strategy for mycophenoloic acid area under the curve. Ther Drug Monit 2000: 22: 169.
14. Bokenkamp A, Offner G, Hoyer PF, Wonigeit K, Brodehl J. Excessive ciclosporine trough level variation with classic ciclosporine can be reduced with the new oral microemulsion ormulation of ciclosporine. Transplant Proc 1996: 28: 2273.
15. Weber LT, Shipkova M, Lamersdorf T et al. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. J Am Soc Nephrol 1998: 9: 1511.